EW vs JCAP · P/E 47, rev $1.39B vs rev $150.8M
Edwards Lifesciences Corp (EW) versus Jefferson Capital, Inc (JCAP) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Jefferson Capital, Inc (JCAP) is a credit services company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported JCAP revenue for 2025-09-30 was $150.8M. Net income was $150.2M. Revenue was down 1.2% from 2025-06-30 to 2025-09-30. JCAP currently screens at market cap $0.
EW currently screens at market cap $49.91B and trailing P/E 46.9. JCAP currently screens at market cap $0.
Not investment advice. Open the EW and JCAP stock pages for the full models.
Not investment advice.